2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Aguilar Laura K. | 10% Owner | 2,013,100 | May 10, 2022 |
| Tak Paul Peter | CEO | 268,566 | Jun 26, 2025 |
| Amello Jason | CFO | 202,009 | Nov 30, 2023 |
| Canepa John J | CFO | 110,000 | Mar 1, 2022 |
| Barone Francesca | Chief Scientific Officer | 100,809 | Jun 26, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 26, 2026 | Manning Paul B | Director | Buy | 100.0 | +550,458 | 10.59% | ✗ | $3M |
| Jan 26, 2026 | Jan 28, 2026 | Tyagarajan Seshu | Chief Technology Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Nichols William Garrett | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Schoch Charles | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Tak Paul Peter | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Barone Francesca | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 28, 2025 | Jul 30, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | 50.0 | -937 | -1.75% | ✓ | $6.5K |
| Jun 30, 2025 | Jul 2, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | 50.0 | -781 | -1.47% | ✓ | $3.9K |
| Jun 25, 2025 | Jun 26, 2025 | Tyagarajan Seshu | Chief Technology Officer | Neutral | 85.0 | +5,353 | 6.26% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Tak Paul Peter | CEO | Neutral | 90.0 | +42,826 | 18.97% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Manning Paul B | Director | Neutral | 90.0 | +1,070,663 | 25.94% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Martell Christopher | Director | Neutral | 90.0 | +111,349 | 25.57% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Schoch Charles | CFO | Neutral | 90.0 | +5,353 | 14.07% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Loggia Nicoletta | Director | Neutral | 90.0 | +2,141 | 100.00% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Nabel Gary J. | Director | Neutral | 90.0 | +5,353 | 100.00% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | Barone Francesca | Chief Scientific Officer | Neutral | 82.5 | +4,282 | 4.44% | ✗ | - |
| Jun 25, 2025 | Jun 26, 2025 | PAPA JOSEPH C | Director | Neutral | 90.0 | +64,239 | 168.91% | ✗ | - |
| Jun 20, 2025 | Jun 24, 2025 | Schoch Charles | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Benz Edward J. JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Gaeta Renee | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Loggia Nicoletta | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Manning Paul B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Martell Christopher | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Nabel Gary J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Nguyen Diem | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | PAPA JOSEPH C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 4, 2025 | Jun 6, 2025 | Radhakrishnan Maha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2025 | Radhakrishnan Maha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 18, 2025 | Mar 20, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | 7.5 | -45,316 | -46.33% | ✓ | $397K |
| Mar 18, 2025 | Mar 20, 2025 | Barone Francesca | Chief Scientific Officer | Sell | 12.5 | -32,146 | -24.98% | ✓ | $281.7K |
| Mar 18, 2025 | Mar 20, 2025 | Tak Paul Peter | CEO | Sell | 25.0 | -26,172 | -10.39% | ✓ | $229.6K |
| Mar 17, 2025 | Mar 20, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell | 7.5 | -31,278 | -26.78% | ✓ | $275.9K |
| Mar 17, 2025 | Mar 19, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell | 7.5 | -31,278 | -26.78% | ✓ | $275.9K |
| Mar 17, 2025 | Mar 19, 2025 | Schoch Charles | Officer | Sell | 28.8 | -5,000 | -11.62% | ✓ | $44.2K |
| Feb 21, 2025 | Feb 25, 2025 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 37.5 | -21,165 | -0.48% | ✗ | $254.4K |
| Feb 12, 2025 | Feb 14, 2025 | Schoch Charles | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2025 | Feb 14, 2025 | Nichols William Garrett | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2025 | Feb 14, 2025 | Tyagarajan Seshu | Chief Technology Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2025 | Feb 14, 2025 | Tak Paul Peter | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2025 | Feb 14, 2025 | Barone Francesca | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 10, 2025 | Feb 13, 2025 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 30.0 | -31,335 | -0.73% | ✗ | $269.8K |
| Jan 15, 2025 | Jan 17, 2025 | Barone Francesca | Chief Scientific Officer | Sell | 42.5 | -13,534 | -10.90% | ✗ | $97.8K |
| Jan 15, 2025 | Jan 17, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell | 42.5 | -14,322 | -12.89% | ✗ | $103.5K |
| Jan 15, 2025 | Jan 17, 2025 | Schoch Charles | Officer | Sell | 42.5 | -9,511 | -18.10% | ✗ | $68.7K |
| Jan 15, 2025 | Jan 17, 2025 | Tak Paul Peter | CEO | Sell | 42.5 | -21,704 | -7.93% | ✗ | $156.8K |
| Jan 15, 2025 | Jan 17, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | 42.5 | -10,428 | -11.62% | ✗ | $75.3K |
| Jan 8, 2025 | Jan 10, 2025 | Barone Francesca | Chief Scientific Officer | Sell | 42.5 | -13,673 | -9.92% | ✗ | $112.4K |
| Jan 8, 2025 | Jan 10, 2025 | Schoch Charles | Officer | Sell | 42.5 | -9,971 | -15.95% | ✗ | $81.9K |
| Jan 8, 2025 | Jan 10, 2025 | Tak Paul Peter | CEO | Sell | 42.5 | -21,172 | -7.18% | ✗ | $174K |
| Jan 8, 2025 | Jan 10, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell | 42.5 | -14,545 | -11.58% | ✗ | $119.5K |
| Jan 8, 2025 | Jan 10, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | 42.5 | -10,799 | -10.74% | ✗ | $88.7K |
| Dec 26, 2024 | Dec 30, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 17.5 | -200,000 | -4.35% | ✗ | $1.8M |
| Dec 20, 2024 | Dec 26, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 17.5 | -300,000 | -5.37% | ✗ | $2.7M |
| Dec 16, 2024 | Dec 18, 2024 | Manning Paul B | Director | Buy | 100.0 | +1,250,000 | 43.45% | ✗ | $7.5M |
| Dec 11, 2024 | Dec 13, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 16.3 | -800,000 | -13.81% | ✗ | $7.4M |
| Dec 4, 2024 | Dec 6, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 20.0 | -60,000 | -1.18% | ✗ | $289.6K |
| Nov 29, 2024 | Dec 3, 2024 | Tyagarajan Seshu | Chief Technology Officer | Sell | 42.5 | -20,392 | -13.96% | ✗ | $92.9K |
| Nov 29, 2024 | Dec 3, 2024 | Tak Paul Peter | CEO | Sell | 42.5 | -48,847 | -14.21% | ✗ | $222.5K |
| Nov 29, 2024 | Dec 3, 2024 | Nichols William Garrett | Chief Medical Officer | Sell | 42.5 | -13,935 | -12.17% | ✗ | $63.5K |
| Nov 29, 2024 | Dec 3, 2024 | Barone Francesca | Chief Scientific Officer | Sell | 42.5 | -22,081 | -13.80% | ✗ | $100.6K |
| Nov 25, 2024 | Nov 27, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 40.0 | -20,000 | -0.39% | ✗ | $99.4K |
| Nov 21, 2024 | Nov 21, 2024 | Tak Paul Peter | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 6, 2024 | Nov 8, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 32.5 | -45,000 | -0.77% | ✗ | $231.6K |
| Oct 30, 2024 | Nov 1, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 32.5 | -42,000 | -0.71% | ✗ | $223.1K |
| Oct 24, 2024 | Oct 28, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 32.5 | -30,929 | -0.53% | ✗ | $172.3K |
| Oct 11, 2024 | Oct 15, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 32.5 | -40,412 | -0.68% | ✗ | $243.8K |
| Oct 1, 2024 | Oct 3, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 40.0 | -22,574 | -0.38% | ✗ | $155.5K |
| Jul 17, 2024 | Jul 19, 2024 | Tyagarajan Seshu | Chief Technology Officer | Sell | 42.5 | -14,851 | -9.23% | ✗ | $96.1K |
| Jul 17, 2024 | Jul 19, 2024 | Tak Paul Peter | CEO | Sell | 42.5 | -22,528 | -6.38% | ✗ | $145.8K |
| Jul 17, 2024 | Jul 19, 2024 | Schoch Charles | Officer | Sell | 42.5 | -9,884 | -13.65% | ✗ | $64K |
| Jul 17, 2024 | Jul 19, 2024 | Nichols William Garrett | Chief Medical Officer | Sell | 42.5 | -10,875 | -8.68% | ✗ | $70.4K |
| Jul 17, 2024 | Jul 19, 2024 | Barone Francesca | Chief Scientific Officer | Sell | 42.5 | -14,051 | -8.07% | ✗ | $90.9K |
| Jul 11, 2024 | Jul 15, 2024 | Tyagarajan Seshu | Chief Technology Officer | Sell | 42.5 | -13,330 | -7.65% | ✗ | $79.6K |
| Jul 11, 2024 | Jul 15, 2024 | Tak Paul Peter | CEO | Sell | 42.5 | -20,293 | -5.43% | ✗ | $121.2K |
| Jul 11, 2024 | Jul 15, 2024 | Schoch Charles | Officer | Sell | 42.5 | -8,897 | -10.94% | ✗ | $53.1K |
| Jul 11, 2024 | Jul 15, 2024 | Nichols William Garrett | Chief Medical Officer | Sell | 42.5 | -9,769 | -7.23% | ✗ | $58.4K |
| Jul 11, 2024 | Jul 15, 2024 | Barone Francesca | Chief Scientific Officer | Sell | 42.5 | -12,645 | -6.77% | ✗ | $75.5K |
| Jun 26, 2024 | Jun 27, 2024 | PAPA JOSEPH C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Nguyen Diem | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Nabel Gary J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Martell Christopher | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Manning Paul B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Loggia Nicoletta | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Gaeta Renee | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2024 | Jun 27, 2024 | Benz Edward J. JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 19, 2024 | Schoch Charles | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 28, 2023 | Nov 30, 2023 | Tyagarajan Seshu | Chief Technology Officer | Sell | 46.3 | -17,328 | -9.05% | ✗ | $15.6K |
| Nov 28, 2023 | Nov 30, 2023 | Tak Paul Peter | CEO | Sell | 46.3 | -43,443 | -10.42% | ✗ | $39.1K |
| Nov 28, 2023 | Nov 30, 2023 | Nichols William Garrett | Chief Medical Officer | Sell | 46.3 | -12,175 | -8.27% | ✗ | $11K |
| Nov 28, 2023 | Nov 30, 2023 | Barone Francesca | Chief Scientific Officer | Sell | 46.3 | -19,748 | -9.57% | ✗ | $17.8K |
| Nov 28, 2023 | Nov 30, 2023 | Amello Jason | CFO | Sell | 46.3 | -20,153 | -9.07% | ✗ | $18.1K |
| Nov 26, 2023 | Nov 28, 2023 | Tak Paul Peter | CEO | Neutral | 90.0 | +180,108 | 76.03% | ✗ | - |
| Nov 26, 2023 | Nov 28, 2023 | Tyagarajan Seshu | Chief Technology Officer | Neutral | 90.0 | +104,516 | 120.08% | ✗ | - |
| Nov 26, 2023 | Nov 28, 2023 | Nichols William Garrett | Chief Medical Officer | Neutral | 90.0 | +88,822 | 151.89% | ✗ | - |
| Nov 26, 2023 | Nov 28, 2023 | Barone Francesca | Chief Scientific Officer | Neutral | 90.0 | +112,790 | 120.48% | ✗ | - |
| Nov 26, 2023 | Nov 28, 2023 | Amello Jason | CFO | Neutral | 90.0 | +125,717 | 130.35% | ✗ | - |
| Jun 28, 2023 | Jun 29, 2023 | Gaeta Renee | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 29, 2023 | Nguyen Diem | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 29, 2023 | Manning Paul B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 29, 2023 | Martell Christopher | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |